1. Home
  2. GSUN vs PHGE Comparison

GSUN vs PHGE Comparison

Compare GSUN & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSUN

Golden Sun Education Group Limited

HOLD

Current Price

$0.33

Market Cap

8.7M

Sector

Real Estate

ML Signal

HOLD

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$5.06

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSUN
PHGE
Founded
1997
2015
Country
China
United States
Employees
N/A
57
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
9.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GSUN
PHGE
Price
$0.33
$5.06
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0M
64.4K
Earning Date
02-12-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.25
52 Week High
$3.90
$8.50

Technical Indicators

Market Signals
Indicator
GSUN
PHGE
Relative Strength Index (RSI) 28.24 44.70
Support Level N/A $0.53
Resistance Level $1.56 $6.28
Average True Range (ATR) 0.16 1.05
MACD -0.04 -0.21
Stochastic Oscillator 2.54 20.49

Price Performance

Historical Comparison
GSUN
PHGE

About GSUN Golden Sun Education Group Limited

Golden Sun Technology Group Ltd operates two principal lines of business: tutorial services and e-commerce services. The company's e-commerce operations currently consist of data analytics-driven marketing and social media promotional services for small and medium-sized businesses on short video platforms based in China. The company's education centers offer two main programs, comprising of foreign language tutorial programs in less commonly taught languages, including, among other things, Spanish and Japanese, provided to individual students as well as to companies and other organizations; and Gaokao repeater tutorial programs, provided to individual students.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: